Indication

MERS (Middle East Respiratory Syndrome)

1 clinical trial

1 product

Clinical trial

A Two-center, Randomized, Double-blind, Placebo-controlled, Phase Ib Study to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-MERS-S_DF-1 in Healthy Study Subjects

Status: Active (not recruiting), Estimated PCD: 2022-11-28

Product